These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 2080622

  • 1. [The effect of benzbromarone on hyperlipidemia in gout].
    Marinchev L, Kŭnev K.
    Vutr Boles; 1990; 29(5):99-102. PubMed ID: 2080622
    [Abstract] [Full Text] [Related]

  • 2. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R, Bresnik W, Müller MM.
    Fortschr Med; 1979 Nov 22; 97(44):2057-61. PubMed ID: 511087
    [Abstract] [Full Text] [Related]

  • 3. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A.
    Arthritis Rheum; 2002 Aug 22; 47(4):356-60. PubMed ID: 12209479
    [Abstract] [Full Text] [Related]

  • 4. Long-term remission from gout associated with fenofibrate therapy.
    Hepburn AL, Kaye SA, Feher MD.
    Clin Rheumatol; 2003 Feb 22; 22(1):73-6. PubMed ID: 12605325
    [Abstract] [Full Text] [Related]

  • 5. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K, Trnavský K.
    Z Rheumatol; 1979 Feb 22; 38(9-10):342-8. PubMed ID: 525067
    [Abstract] [Full Text] [Related]

  • 6. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F.
    Med Klin (Munich); 1992 Sep 15; 87(9):460-2. PubMed ID: 1406482
    [Abstract] [Full Text] [Related]

  • 7. Benzbromarone therapy in management of refractory gout.
    Kumar S, Ng J, Gow P.
    N Z Med J; 2005 Jun 24; 118(1217):U1528. PubMed ID: 15980902
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P, Akkasilpa S, Deesomchok U.
    J Med Assoc Thai; 2002 Jun 24; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jan 24; 68(1):51-6. PubMed ID: 18250112
    [Abstract] [Full Text] [Related]

  • 10. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M, Ikegami M, Ishii T, Nishioka T, Uemura T, Kunikata S, Kanda H, Matsuura T, Akiyama T, Kurita T.
    Hinyokika Kiyo; 1990 Aug 24; 36(8):893-6. PubMed ID: 2239590
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].
    Matzkies F, Berg G, Minzlaff R.
    Fortschr Med; 1977 Jul 21; 95(27):1748-50. PubMed ID: 332605
    [Abstract] [Full Text] [Related]

  • 12. [The use of Allomaron in treating hyperuricemia].
    Balkarov IM.
    Ter Arkh; 1994 Jul 21; 66(1):40-2. PubMed ID: 8146793
    [No Abstract] [Full Text] [Related]

  • 13. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H.
    Z Gesamte Inn Med; 1990 Dec 01; 45(23):719-20. PubMed ID: 2102029
    [Abstract] [Full Text] [Related]

  • 14. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F, Neuwirth R, Berg G.
    Fortschr Med; 1976 Sep 16; 94(26):1427-9. PubMed ID: 976920
    [Abstract] [Full Text] [Related]

  • 15. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
    Wolfram G, Keller C, Kilani C, Zöllner N.
    Verh Dtsch Ges Inn Med; 1973 Sep 16; 79():1291-3. PubMed ID: 4597609
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
    Brzozowska-Jurkowska AM.
    Reumatologia; 1980 Sep 16; 18(3):287-92. PubMed ID: 6999575
    [No Abstract] [Full Text] [Related]

  • 17. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S, Osiri M, Deesomchok U, Avihingsanon Y.
    J Med Assoc Thai; 2004 Sep 16; 87(9):1087-91. PubMed ID: 15516011
    [Abstract] [Full Text] [Related]

  • 18. Gout and hyperlipidaemia. Effect of overweight on the levels of circulating lipids.
    Rondier J, Truffert J, le Gô A, Cayla J, Hila A, de Gennes JL, Delbarre F.
    Ann Clin Res; 1977 Aug 16; 9(4):239-45. PubMed ID: 616208
    [Abstract] [Full Text] [Related]

  • 19. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR, Dreykluft HR, Leonhardt H.
    Fortschr Med; 1979 Jul 19; 97(27):1212-4. PubMed ID: 457017
    [Abstract] [Full Text] [Related]

  • 20. [Effect of tibric acid (CP-18.254) on plasma lipids in patients with primary endogenous hyperlipoproteinemia].
    Lisch HJ, Sailer S, Braunsteiner H.
    Arzneimittelforschung; 1977 Jul 19; 27(10):2017-20. PubMed ID: 579116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.